Your cart is currently empty!
CJC-1295/Ipamorelin
Price range: $52.00 through $520.00
What is CJC-1295/Ipamorelin? This blend combines CJC-1295 (No DAC) and Ipamorelin, each at 5mg, two synthetic peptides that have been studied for their potential to promote growth hormone (GH) release in preclinical models without significantly affecting cortisol or prolactin levels. Research suggests that this combination may influence pathways related to lean muscle support, recovery, and metabolic regulation. For Research Use Only. Not intended for human consumption, medical, diagnostic, or therapeutic applications.
Description
| Chemical Formula |
CJC-1295 (No DAC / Mod GRF 1-29): C152H252N44O42 Ipamorelin: C38H49N9O5 |
| Molecular Mass |
CJC-1295 (No DAC / Mod GRF 1-29): ~3367.90 Da Ipamorelin: ~711.85 Da |
| CAS Number |
CJC-1295 (No DAC / Mod GRF 1-29): 863288-34-0 Ipamorelin: 170851-70-4 |
| Form | Lyophilized peptide blend |
| Shelf Life | 24 months (lyophilized) |
| Intended Use | For preclinical and in vitro research only |
| Storage | −20 °C (dry powder), −80 °C (after reconstitution) |
In experimental research settings, the CJC-1295 (No DAC) / Ipamorelin blend is used as a paired tool-compound system to investigate complementary growth hormone secretagogue pathways under controlled conditions. CJC-1295 (No DAC / Mod GRF 1-29) is commonly used to study GHRH-receptor–linked signaling dynamics, while ipamorelin is used to evaluate GHSR-mediated signaling and downstream second-messenger responses.
Preclinical investigations frequently employ this combination to explore pathway interaction, pulse-pattern signaling behavior, and comparative signaling kinetics versus single-agent models. Experimental outcomes may vary by assay design, model system, exposure duration, and analytical endpoint selection.
Intended for laboratory research use only. Not for human or animal consumption, medical diagnosis, or therapeutic application.
Additional information
| Volume | 5MG/5MG, KIT (10 x 5/5MG) |
|---|
Description
| Chemical Formula |
CJC-1295 (No DAC / Mod GRF 1-29): C152H252N44O42 Ipamorelin: C38H49N9O5 |
| Molecular Mass |
CJC-1295 (No DAC / Mod GRF 1-29): ~3367.90 Da Ipamorelin: ~711.85 Da |
| CAS Number |
CJC-1295 (No DAC / Mod GRF 1-29): 863288-34-0 Ipamorelin: 170851-70-4 |
| Form | Lyophilized peptide blend |
| Shelf Life | 24 months (lyophilized) |
| Intended Use | For preclinical and in vitro research only |
| Storage | −20 °C (dry powder), −80 °C (after reconstitution) |
In experimental research settings, the CJC-1295 (No DAC) / Ipamorelin blend is used as a paired tool-compound system to investigate complementary growth hormone secretagogue pathways under controlled conditions. CJC-1295 (No DAC / Mod GRF 1-29) is commonly used to study GHRH-receptor–linked signaling dynamics, while ipamorelin is used to evaluate GHSR-mediated signaling and downstream second-messenger responses.
Preclinical investigations frequently employ this combination to explore pathway interaction, pulse-pattern signaling behavior, and comparative signaling kinetics versus single-agent models. Experimental outcomes may vary by assay design, model system, exposure duration, and analytical endpoint selection.
Intended for laboratory research use only. Not for human or animal consumption, medical diagnosis, or therapeutic application.
Additional information
| Volume | 5MG/5MG, KIT (10 x 5/5MG) |
|---|
Reviews
There are no reviews yet.
Related products
-
IGF1-LR3
Price range: $70.00 through $600.00 -
Sermorelin
$30.00 -
Tesamorelin
Price range: $60.00 through $700.00
Reviews
There are no reviews yet.